The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The burden of neuropathic pain: A systematic review and meta-analysis of health utilities
Abstract
Patients with neuropathic pain (NeuP) experience substantially lower health-related quality of life (HRQoL) than the general population. The aim of this systematic review and meta-analysis is to test the hypothesis that NeuP is associated with low levels of health utility. A structured search of electronic databases (MEDLINE, EMBASE, Cochrane Library and CINAHL) was undertaken. Reference lists of retrieved reports were also reviewed. Studies reporting utility single-index measures (preference based) in NeuP were included. Random effects meta-analysis was used to pool EQ-5D index utility estimates across NeuP conditions. The association of utilities and pre-defined factors (NeuP condition, patient age, sex, duration and severity of pain and method of utility scoring) was examined using meta-regression. Twenty-four studies reporting health utility values in patients with NeuP were included in the review. Weighted pooled utility score across the studies varied from a mean of 0.15 for failed back surgery syndrome to 0.61 for post-herpetic neuralgia and diabetic neuropathy. Although there was substantial heterogeneity (P<0.0001) across studies, we found little variation in utility as a function of patient and study characteristics. The single exception was a significant relationship (P<0.0001) between increasing neuropathic pain severity and a reduction in utility. This study confirms the hypothesis that patients with NeuP experience low utilities and therefore low HRQoL. However, the contribution of non-NeuP co-morbidity remains unclear. Neuropathic pain severity emerged as a primary predictor of the negative health impact of NeuP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Classification of chronic pain
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,044
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Oral Health-related Quality of Life: What, Why, How, and Future Implications
Sischo, L., & Broder, H. L. (2011) · Journal of Dental Research · doi:10.1177/0022034511399918 · Cited by 1,448
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Self-citationEFNS guidelines on neurostimulation therapy for neuropathic pain
Cruccu, G., Aziz, T. Z., Garcia‐Larrea, L., Hansson, P., Jensen, T. S., Lefaucheur, J. ‐., Simpson, B. A., & Taylor, R. S. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01916.x · Cited by 690
Self-citationThe impact of neuropathic pain on health-related quality of life: Review and implications
Jensen, M. P., Chodroff, M. J., & Dworkin, R. H. (2007) · Neurology · doi:10.1212/01.wnl.0000259085.61898.9e · Cited by 575
Self-citationO'Connor (2009) · doi:10.2165/00019053-200927020-00002 · Cited by 438
(1994) · Medical Entomology and Zoology · Cited by 393
Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000182493.57090.c1 · Cited by 383 · cited 1×
“The choice and scoring of health utility instrument can affect the utility score [13,14].”
BackgroundThe burden of neuropathic pain: results from a cross‐sectional survey
McDermott, A. M., Toelle, T. R., Rowbotham, D. J., Schaefer, C. P., & Dukes, E. M. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.01.014 · Cited by 374
Health Utilities Using the EQ-5D in Studies of Cancer
Pickard, A. S., Wilke, C. T., Lin, H.-W., & Lloyd, A. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725050-00002 · Cited by 285
Comparison of the EQ-5D and SF-12 Health Surveys in a General Population Survey in Alberta, Canada
Johnson, J. A., & Pickard, A. S. (2000) · Medical Care · doi:10.1097/00005650-200001000-00013 · Cited by 274
Manca, A., Kumar, K., Taylor, R. S., Jacques, L., Eldabe, S., Meglio, M., Molet, J., Thomson, S., O'Callaghan, J., Eisenberg, E., et al. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.01.014 · Cited by 215
Self-citationA Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials
Clayson, D. J., Wild, D. J., Quarterman, P., Duprat-Lomon, I., Kubin, M., & Coons, S. J. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624080-00003 · Cited by 175
A comparison of the SF‐36 and Nottingham Health Profile in patients with chronic neuropathic pain
Meyer-Rosberg, K., Burckhardt, C. S., Huizar, K., Kvarnström, A., Nordfors, L., & Kristofferson, A. (2001) · European Journal of Pain · doi:10.1053/eujp.2001.0260 · Cited by 127
Relevance of Cost-effectiveness Analysis to Clinicians and Policy Makers
Detsky, A. S., & Laupacis, A. (2007) · JAMA · doi:10.1001/jama.298.2.221 · Cited by 109
A Review and Meta-Analysis of Prostate Cancer Utilities
Bremner, K. E., Chong, C. A. K. Y., TOMLINSON, G. A., Alibhai, S. M. H., & Krahn, M. D. (2007) · Medical Decision Making · doi:10.1177/0272989x07300604 · Cited by 104
Quality of Life and Pharmacoeconomics: An Introduction
Cramer, J. A., & Spilker, B. (1998) · Cited by 77
A cost-utility analysis of interferon beta for multiple sclerosis.
Parkin, McNamee, P., Jacoby, Miller, M. A., Thomas, & Bates (1998) · Health Technology Assessment · doi:10.3310/hta2040 · Cited by 77
Cited by
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Self-citationThe Epidemiology and Economic Consequences of Pain
Henschke, N., Kamper, S. J., & Maher, C. G. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.09.010 · Cited by 490
Moisset, X., Bouhassira, D., Avez Couturier, J., Alchaar, H., Conradi, S., Delmotte, M. H., Lanteri-Minet, M., Lefaucheur, J. P., Mick, G., Piano, V., et al. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.361 · Cited by 450
The specific disease burden of neuropathic pain: Results of a French nationwide survey
Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., & Bouhassira, D. (2011) · Pain · doi:10.1016/j.pain.2011.09.014 · Cited by 427
Andrew, R., Derry, S., Taylor, R. S., Straube, S., & Phillips, C. J. (2014) · Pain Practice · doi:10.1111/papr.12050 · Cited by 375
Self-citation
Metadata
- Authors
- Doth, A. H., Hansson, P. T., Jensen, M. P., & Taylor, R. S.
- Venue
- Pain
- Published
- 2010-05
- Volume
- 149
- Issue
- 2
- Pages
- 338-344
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1988364618
- Cited by
- 346
- References
- 22
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.